Imagine a Clinical Trial System that Seamlessly Designs Trials

Some men see things as they are and ask why. Others dream things that never were and ask why not.”

― George Bernard Shaw

Imagine a clinical trial system that seamlessly designs trials; monitors and continuously evaluates running trials alerting administrators of potential problems as they arise; performs analyses with no programming; and enables access and benefits patients, including those who are underserved. In the design phase, this system uses knowledge of previous trials, their patient populations, and current international drug development regulations to reduce both the number of patients required and the amount of time needed for the trial, all while being compliant in multiple countries. In the execution phase, investigators can query the system to monitor trial status and patient populations as data are received through interactive visualizations and tables. When needed, they can consult with a statistical expert to construct scientific hypotheses critical to understanding causal pathways with results provided in hours or even minutes rather than weeks or months. The system makes sure that the trial’s lead is aware of the administrative status of the trial including trial enrollment, site performance, and trial data integrity continuously identifying issues as they occur. If the trial is a success, decision makers deciding how or if to proceed on the drug-development journey are made aware of how likely the drug is to attain approval in future phase and its impact in the market. It provides a complete view of the trial, based on current trial telemetry and an archive of historical trials, achieving total trial intelligence (TTI).

“Everything you can imagine is real.”

― Pablo Picaso

At Telperian we imagined the vision into reality. The Telperian Foundation & Prime Radiant platforms are interactive, amplifying biostatistician productivity tenfold, while also empowering non-biostatisticians with advanced clinical trial data analytics capabilities. With team collaboration imagined at its heart, the permission-driven platforms provide the entire clinical trial execution team with a complete view of a trial, combining historical data from the latest and most relevant private and public data sources with the telemetry of the ongoing trial.

The Telperian platforms are positioned to revolutionize clinical trials through seamless integration of ML/AI technology, expediting development of effective therapies, fostering a healthier future through smarter and more efficient development processes.